JPWO2023059857A5 - - Google Patents

Info

Publication number
JPWO2023059857A5
JPWO2023059857A5 JP2024520887A JP2024520887A JPWO2023059857A5 JP WO2023059857 A5 JPWO2023059857 A5 JP WO2023059857A5 JP 2024520887 A JP2024520887 A JP 2024520887A JP 2024520887 A JP2024520887 A JP 2024520887A JP WO2023059857 A5 JPWO2023059857 A5 JP WO2023059857A5
Authority
JP
Japan
Prior art keywords
influenza virus
machine
immunogenic composition
learned
learning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024520887A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024537180A (ja
JP2024537180A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/045992 external-priority patent/WO2023059857A1/en
Publication of JP2024537180A publication Critical patent/JP2024537180A/ja
Publication of JPWO2023059857A5 publication Critical patent/JPWO2023059857A5/ja
Publication of JP2024537180A5 publication Critical patent/JP2024537180A5/ja
Pending legal-status Critical Current

Links

JP2024520887A 2021-10-08 2022-10-07 多価インフルエンザワクチン Pending JP2024537180A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163253986P 2021-10-08 2021-10-08
US63/253,986 2021-10-08
US202163277848P 2021-11-10 2021-11-10
US63/277,848 2021-11-10
PCT/US2022/045992 WO2023059857A1 (en) 2021-10-08 2022-10-07 Multivalent influenza vaccines

Publications (3)

Publication Number Publication Date
JP2024537180A JP2024537180A (ja) 2024-10-10
JPWO2023059857A5 true JPWO2023059857A5 (https=) 2025-10-15
JP2024537180A5 JP2024537180A5 (https=) 2025-10-15

Family

ID=84330622

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024520887A Pending JP2024537180A (ja) 2021-10-08 2022-10-07 多価インフルエンザワクチン

Country Status (10)

Country Link
US (1) US20240269258A1 (https=)
EP (1) EP4412647A1 (https=)
JP (1) JP2024537180A (https=)
KR (1) KR20240076825A (https=)
AU (1) AU2022361432A1 (https=)
CA (1) CA3233926A1 (https=)
IL (1) IL311964A (https=)
MX (1) MX2024004252A (https=)
TW (1) TW202333778A (https=)
WO (1) WO2023059857A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4727579A1 (en) * 2023-06-19 2026-04-22 Seqirus Inc. Multivalent subtype influenza vaccine
KR20260017552A (ko) 2024-07-29 2026-02-06 한림대학교 산학협력단 바이러스 감염증의 예방 또는 치료를 위한 약학적 조성물

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4886499A (en) 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
US5762939A (en) 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
ATE509102T1 (de) 1994-07-15 2011-05-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
WO1998037919A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
AU7690898A (en) 1997-05-20 1998-12-11 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
ATE356630T1 (de) 1998-04-03 2007-04-15 Univ Iowa Res Found Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
US9452209B2 (en) * 2007-04-20 2016-09-27 Glaxosmithkline Biologicals Sa Influenza vaccine
HUE042177T2 (hu) 2009-12-01 2019-06-28 Translate Bio Inc Szteroidszármazék mRNS szállítására humán genetikai betegségekben
EP3157557A1 (en) * 2014-06-20 2017-04-26 The U.S.A. as represented by the Secretary, Department of Health and Human Services Polyvalent influenza virus-like particles (vlps) and use as vaccines
WO2019032463A1 (en) * 2017-08-07 2019-02-14 Icahn School Of Medicine At Mount Sinai IMMUNOGENIC COMPOSITIONS COMPRISING INFLUENZA VIRUS AND AS01 CHIMERIC POLYPEPTIDES OF HEMAGGLUTININ AND USES THEREOF
WO2019143955A1 (en) * 2018-01-22 2019-07-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Broadly protective inactivated influenza virus vaccine
US12579423B2 (en) 2019-10-21 2026-03-17 Sanofi Pasteur, Inc. Systems and methods for predicting biological responses
WO2021080990A1 (en) 2019-10-21 2021-04-29 Sanofi Pasteur, Inc. Systems and methods for designing vaccines
IL302397A (en) 2020-10-28 2023-06-01 Sanofi Pasteur Liposomes containing a TLR4 agonist, their preparation and uses

Similar Documents

Publication Publication Date Title
Fan et al. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys
Epstein et al. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice
Perrone et al. Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge
Kodihalli et al. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines
US12064478B2 (en) Methods of making and using universal centralized influenza vaccine genes
Zhang et al. Advancements in the development of subunit influenza vaccines
Wang et al. Heterologous HA DNA vaccine prime—inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses
Babapoor et al. A novel vaccine using nanoparticle platform to present immunogenic M2e against avian influenza infection
Ryder et al. Vaccination with vesicular stomatitis virus-vectored chimeric hemagglutinins protects mice against divergent influenza virus challenge strains
US9505806B2 (en) DNA vaccine, method of inducing the immune response, method of immunisation, antibodies specifically recognising the H5 haemagglutinin of an influenza virus and use of the DNA vaccine
US9504741B2 (en) Immune methods against influenza viruses and combinatorial vaccines thereof
CN104203272A (zh) 复合抗原序列及疫苗
Schultz-Cherry et al. Influenza vaccines: the good, the bad, and the eggs
EP2650362A9 (en) Novel vaccines against the a/h1n1 pandemic flu virus
JPH0789992A (ja) 免疫原性人工ポリペプチド
Horimoto et al. Designing vaccines for pandemic influenza
Meseda et al. Immunogenicity and protection against influenza H7N3 in mice by modified vaccinia virus Ankara vectors expressing influenza virus hemagglutinin or neuraminidase
Zhao et al. An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus
Cox et al. Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5–7 May 2014
Suguitan Jr et al. Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets
JPWO2023059857A5 (https=)
Soleimani et al. Improvement influenza HA2 DNA vaccine cellular and humoral immune responses with Mx bio adjuvant
Wu et al. Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines
CN101732716A (zh) 用于预防和/或治疗禽流感的抗原抗体复合物
MX2013004975A (es) Vacunas novedosas contra el virus pandémico de la influenza a/h1n1.